ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01533207
Brief Title: Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery

First Submitted : February 11, 2012
First Submitted that Met QC Criteria : February 11, 2012
First Posted : February 15, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : August 23, 2017
Last Update Posted : August 24, 2017